BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12627850)

  • 1. Multicenter prospective study of clonal complications in adult aplastic anemia patients following recombinant human granulocyte colony-stimulating factor (lenograstim) administration.
    Bessho M; Hotta T; Ohyashiki K; Takahashi T; Mizoguchi H; Asano S; Ikeda Y; Sakurai M; Tojo A; Kizaki M; Iwanaga M; Tomonaga M; Hirashima K
    Int J Hematol; 2003 Feb; 77(2):152-8. PubMed ID: 12627850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clonal chromosomal aberrations in patients with aplastic anemia at the disease onset and transformation].
    Ol'shanskaia IuV; Mikhaĭlova EA; Domracheva EV; Udovichenko AI; Davidian IuR; Vodinskaia LA; Zakharova AV; Kokhno AV; Kaplanskaia IB; Tikhonova LIu; Tsvetaeva NV; Parovichnikova EN; Savchenko VG
    Ter Arkh; 2006; 78(7):31-4, 36-7. PubMed ID: 16944748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evidence of clonal evolution with monosomy 7 in aplastic anemia following granulocyte colony-stimulating factor using the polymerase chain reaction.
    Yamazaki E; Kanamori H; Taguchi J; Harano H; Mohri H; Okubo T
    Blood Cells Mol Dis; 1997 Aug; 23(2):213-8. PubMed ID: 9236159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
    Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
    Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myelodysplastic syndrome with monosomy 7 following combination therapy with granulocyte colony-stimulating factor, cyclosporin A and danazole in an adult patient with severe aplastic anemia].
    Tsuzuki M; Okamoto M; Yamaguchi T; Ino T; Ezaki K; Hirano M
    Rinsho Ketsueki; 1997 Sep; 38(9):745-51. PubMed ID: 9364865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [RAEB in T with monosomy 7 after treatment of severe aplastic anemia with long term G-CSF].
    Kaito K; Otsubo H; Ogasawara Y; Sekita T; Saeki A; Nishiwaki K; Masuoka H; Shimada T; Kobayashi M; Sakai O
    Rinsho Ketsueki; 1995 Apr; 36(4):365-70. PubMed ID: 7540227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of myelodysplastic syndrome/ acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF.
    Imashuku S; Hibi S; Bessho F; Tsuchida M; Nakahata T; Miyazaki S; Tsukimoto I; Hamajima N;
    Haematologica; 2003 Nov; 88(11):ECR31. PubMed ID: 14607763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
    Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor).
    Sonoda Y; Ohno Y; Fujii H; Takahashi T; Nakayama S; Haruyama H; Nasu K; Shimazaki C; Hara H; Kanamaru A
    Stem Cells; 1993 Nov; 11(6):543-54. PubMed ID: 7509223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience.
    Li Y; Li X; Ge M; Shi J; Qian L; Zheng Y; Wang J
    Ann Hematol; 2011 May; 90(5):529-37. PubMed ID: 21207031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation of severe aplastic anemia into myelodysplastic syndrome with monosomy 7: monoclonal origin detected by HUMARA gene analysis during the aplastic anemia phase.
    Sashida G; Tauchi T; Katagiri T; Kuriya S; Ohyashiki K
    Haematologica; 2000 Jun; 85(6):665-6. PubMed ID: 10870128
    [No Abstract]   [Full Text] [Related]  

  • 13. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations.
    Tehranchi R; Fadeel B; Schmidt-Mende J; Forsblom AM; Emanuelsson E; Jadersten M; Christensson B; Hast R; Howe RB; Samuelsson J; Zhivotovsky B; Hellström-Lindberg E
    Clin Cancer Res; 2005 Sep; 11(17):6291-9. PubMed ID: 16144933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of G-CSFR and GM-CSFR expressions on CD34+ cells in patients with aplastic anemia and myelodysplastic syndrome.
    Xu H; Li A; Yu Y; Li J; Liu X; Wang X; Wang X; Xu G
    Int J Lab Hematol; 2009 Dec; 31(6):597-602. PubMed ID: 18637807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful bone marrow plus cord blood stem cell transplantation in a girl who developed myelodysplastic syndrome from hepatitis-associated aplastic anemia treated with long-term immunosuppressants and growth factors.
    Shibuya A; Ishii S; Obinata K
    Hematology; 2002 Oct; 7(5):301-4. PubMed ID: 12850817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group.
    Remacha AF; Arrizabalaga B; Villegas A; Manteiga R; Calvo T; Julià A; Fernández Fuertes I; González FA; Font L; Juncà J; del Arco A; Malcorra JJ; Equiza EP; de Mendiguren BP; Romero M
    Haematologica; 1999 Dec; 84(12):1058-64. PubMed ID: 10586205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic instability in bone marrow failure syndromes.
    Kearns WG; Sutton JF; Maciejewski JP; Young NS; Liu JM
    Am J Hematol; 2004 Jul; 76(3):220-4. PubMed ID: 15224355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chromosomal aberrations in myelodysplastic syndrome].
    Ol'shanskaia IuV; Domracheva EV; Udovichenko AI; Vodinskaia LA; Zakharova AV; Parovichnikova EN; Tsvetaeva NV; Mikhaĭlova EA; Glasko EN; Kolosova LIu; Kokhno AN; Tikhonova LIu; Shitareva TV; Smirnova EA; Alimova GA; Shirin AD; Vinogradova OIu; Khoroshko ND; Savchenko VG
    Ter Arkh; 2005; 77(7):27-33. PubMed ID: 16116905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aplastic anemia and monosomy 7-associated dysmegakaryocytopoiesis.
    Dolan MM; Singleton TP; Neglia J; Cioc A
    Am J Clin Pathol; 2006 Dec; 126(6):925-30. PubMed ID: 17074689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.